Search
Aspire Biopharma Holdings Inc
ASBPAdd to Watchlist
6.680USD
-0.040-0.60%
Close 07-31 16:00（ET）Quotes delayed by 15 min
590.08KMarket Cap
LossP/E TTM
Aspire Biopharma Holdings Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Aspire Biopharma Holdings Inc is 7.07, ranking 219 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.93, which is -23.93% below the recent high of -0.71 and -19.02% above the recent low of -1.11.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.